NCT04391049 2026-01-30
Testing the Addition of the Anti-cancer Viral Therapy Telomelysinâ„¢ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery
NRG Oncology
Phase 1 Active not recruiting
Clinical Trials
11 trialsNCT02819752 2026-01-21
PEACH
Royal Marsden NHS Foundation Trust
Phase 1 Terminated
NCT03641547 2024-07-18
CHARIOT
University of Oxford
Phase 1 Completed
NCT02229656 2023-11-07
Olaparib and Radiotherapy in Head and Neck Cancer
The Netherlands Cancer Institute
Phase 1 Unknown
NCT02158234 2023-01-19
Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and Neck
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT01445405 2019-12-17
Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00011778 2019-12-12
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT02107235 2017-06-23
Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer
Traws Pharma, Inc.
Phase 1 Completed
NCT01737008 2016-06-13
Dacomitinib Plus Radiotherapy, With and Without Cisplatin in Patients With Squamous Cell Carcinoma of the Head and Neck
University Health Network, Toronto
Phase 1 Completed
NCT00113347 2012-02-27
Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00001442 2008-03-04
A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Completed